Global epidemiology of atrial fibrillation: An increasing epidemic and public health challenge

Background Atrial fibrillation is the most frequent cardiac arrhythmia. It has been estimated that 6–12 million people worldwide will suffer this condition in the US by 2050 and 17.9 million people in Europe by 2060. Atrial fibrillation is a major risk factor for ischemic stroke and provokes important economic burden along with significant morbidity and mortality. Aim We provide here comprehensive and updated statistics on worldwide epidemiology of atrial fibrillation. Methods An electronic search was conducted for atrial fibrillation. The epidemiologic information was retrieved from the Global Health Data Exchange database, which is regarded as one of the most comprehensive worldwide catalogs of surveys, censuses, vital statistics, and other health-related data. Results A total of 3.046 million new cases of atrial fibrillation worldwide were registered in the database during 2017. The estimated incidence rate for 2017 (403/millions inhabitants) was 31% higher than the corresponding incidence in 1997. The worldwide prevalence of atrial fibrillation is 37,574 million cases (0.51% of worldwide population), increased also by 33% during the last 20 years. The highest burden is seen in countries with high socio-demographic index, though the largest recent increased occurred in middle socio-demographic index countries. Future projections suggest that absolute atrial fibrillation burden may increase by >60% in 2050. Conclusions Our analyses suggest that atrial fibrillation incidence and prevalence have increased over the last 20 years and will continue to increase over the next 30 years, especially in countries with middle socio-demographic index, becoming one of the largest epidemics and public health challenges.

[1]  R. Schnabel,et al.  The imminent epidemic of atrial fibrillation and its concomitant diseases – Myocardial infarction and heart failure - A cause for concern , 2019, International journal of cardiology.

[2]  G. Lip,et al.  Stroke prevention in atrial fibrillation: State of the art. , 2019, International journal of cardiology.

[3]  G. Lip,et al.  Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis , 2019, PloS one.

[4]  M. Lown,et al.  Should we screen for atrial fibrillation? , 2019, BMJ.

[5]  K. Mukherjee,et al.  Impact of atrial fibrillation on inpatient cost for ischemic stroke in the USA , 2019, International journal of stroke : official journal of the International Stroke Society.

[6]  Haniye Sadat Sajadi,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2018, The Lancet.

[7]  T. Marshall,et al.  Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies , 2018, British Medical Journal.

[8]  R. Tieleman,et al.  Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE) , 2018 .

[9]  G. Lip,et al.  Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Elect , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[10]  Prashanthan Sanders,et al.  Modifiable Risk Factors and Atrial Fibrillation , 2017, Circulation.

[11]  G. Lip,et al.  Stroke prevention in atrial fibrillation: Past, present and future , 2017, Thrombosis and Haemostasis.

[12]  P. Kirchhof,et al.  Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration , 2017, Circulation.

[13]  A. Banerjee,et al.  Are Cardiovascular Risk Factors also Associated with the Incidence of Atrial Fibrillation? , 2017, Thrombosis and Haemostasis.

[14]  G. Lip,et al.  European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS) , 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  G. Lippi,et al.  Atrial fibrillation in highly trained endurance athletes - Description of a syndrome. , 2017, International journal of cardiology.

[16]  G. Lip,et al.  Screening for Atrial Fibrillation : a European Heart Rhythm Association ( EHRA ) consensus document endorsed by the Heart Rhythm Society ( HRS ) , Asia Pacific Heart Rhythm Society ( APHRS ) , and Societad Latinoamericana de Estimulation , 2018 .

[17]  M. Zoni-Berisso,et al.  Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.

[18]  Vikas Singh,et al.  Contemporary Trends of Hospitalization for Atrial Fibrillation in the United States, 2000 Through 2010: Implications for Healthcare Planning , 2014, Circulation.

[19]  Samuel Wann,et al.  Atrial Fibrillation: Prevalence and Scope of the Problem. , 2014, Cardiac electrophysiology clinics.

[20]  George A Mensah,et al.  Global burden of atrial fibrillation in developed and developing nations. , 2014, Global heart.

[21]  M. Gollob,et al.  A contemporary review on the genetic basis of atrial fibrillation. , 2014, Methodist DeBakey cardiovascular journal.

[22]  Albert Hofman,et al.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. , 2013, European heart journal.

[23]  G. Lip,et al.  Recent developments in understanding epidemiology and risk determinants of atrial fibrillation as a cause of stroke. , 2013, The Canadian journal of cardiology.

[24]  Thomas Wilke,et al.  Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patients. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[25]  V. Gudnason,et al.  Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[26]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.